Medikamentöse Therapie bei Patienten mit Leberzirrhose: Aktueller Stand und zukünftige Entwicklungen

Liver cirrhosis is the end stage of chronic liver disease and is associated with high morbidity and mortality, especially in advanced stages. Patients with liver cirrhosis are permanently at risk of a variety of serious complications. Optimal pharmacological management in patients with liver cirrhosis can slow progression of the underlying disease, improve quality of life, avoid hospitalizations by preventing complications, and reduce mortality by treating hepatic decompensation. In this article, we provide an overview of the current status and new developments in pharmacotherapy in patients with liver cirrhosis.